CellFE Announces Addition of Life Science Tools Veteran Mike Rice to Board of Directors
CellFE Appoints Mike Rice to Board of Directors
News
Categories
CellFE Announces Presentations at International Society of Gene & Cell Therapy (ISCT) 2024 Annual Meeting
CellFE announced today an upcoming presentation by CEO Alla Zamarayeva, PhD, at the International Society of Gene & Cell Therapy (ISCT) Annual Meeting, taking place May 29-June 1, 2024 in Vancouver, BC.
CellFE Announces May 2024 Conference Presentations
CellFE announced today an upcoming presentation by CSO Todd Sulchek, PhD, at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting, taking place May 7-11, 2024 in Baltimore, MD.
CellFE secures $22 million in Series A financing to advance microfluidics-based cellular engineering platform
CellFE announced the completion of a $22 million Series A financing led by M Ventures, with participation from Great Point Ventures, Riverine Ventures and its existing investors.
Endpoints News: CellFE raises $22M Series A to advance a new cell therapy manufacturing idea
Exclusive: The California-based startup CellFE has raised a $22 million Series A to advance a new approach to making cell therapies with microfluidics.
CellFE unveils research scale microfluidics-based cell engineering platform at BIO2022
The BIO International Convention (BIO) returns to in person meetings in San Diego, CA June 13-16 and CellFE will be there to present the…
CEO and Co-Founder Alla Zamarayeva presents in the Startup Showcase session at the ASGCT Annual
CEO and Co-Founder Alla Zamarayeva PhD presented recently at the Startup Showcase at the ASGCT 25th Annual Conference.
CellFE Co-Founder Joins 10 Women-led Companies in Springboard Enterprise’s 2022 Innovation Bootcamp
Alla Zamarayeva, Co-Founder and CEO, has joined 10 women-led companies to participate in Springboard Enterprise’s 2022 Life Sciences Innovation Bootcamp.
CellFE co-founder Todd Sulchek, PhD presented at Cellicon Valley ‘21
Todd Sulchek, PhD, Co-founder of CellFE and Head of the Sulchek BioMEMS & Biomechanics Lab at Georgia Tech, will be participating as a speaker…
CellFE Closes Series Seed Funding Round
CellFE announced it has raised $3.6 million in an initial Series Seed, co-led by Cota Capital and Dynamk Capital, and joined by Embark Ventures.
CellFE to Participate in NIIMBL Funded Project
CellFE will participate in one of 15 funded projects as part of $9M in funding by the National Institute for Innovation in Manufacturing Biopharmaceuticals…